Last winter, I donated my kidney to a stranger. As a nephrologist, I see people every day who need a gently used kidney, and ...

My illness previously dictated how I planned my days, years and entire sense of possibility – pregnancy has disrupted that ...

Now, it’s worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

The iBox Scoring System is a novel composite biomarker endpoint predictive of long-term graft survival after kidney ...

Novartis has claimed accelerated approval from the FDA for Vanrafia, one of a trio of therapies it hopes will revolutionise the treatment of rare kidney disease IgA nephropathy (IgAN). Vanrafia ...

Otsuka and Vera Therapeutics have both presented new data on drug candidates for IgA nephropathy (IgAN), striving to join a market which is becoming increasingly crowded.

Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

When you think of hematuria, you think of a state in which your urine is mixed with red blood. However, the presence of ...

As July draws to a close, it's time to take a look at what's in store in the health and wellness space over the upcoming weeks.August, the last month of summer, includes several ...

Jim Sollisch has led what he calls an “ordinary” life. Yet, even in the everyday, magic can be found. Sollisch discovered ...